Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tramazoline hydrochloride (substance) |
Is a |
False |
Tramazoline (substance) |
Inferred relationship |
Some |
|
Product containing tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tramazoline (substance) |
Inferred relationship |
Some |
|
Tramazoline-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
1 |
Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
2 |
Tramazoline hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
|
Product containing only dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
2 |
Product containing only tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
1 |
Dexamethasone and tramazoline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
2 |
Tramazoline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tramazoline (substance) |
Inferred relationship |
Some |
1 |